Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

John Arcaroli

Concepts (368)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Colorectal Neoplasms
19
2018
749
2.630
Why?
Xenograft Model Antitumor Assays
21
2024
808
1.520
Why?
Antineoplastic Agents
17
2018
2046
1.410
Why?
Drug Resistance, Neoplasm
7
2016
752
1.080
Why?
Benzodioxoles
3
2012
106
1.040
Why?
Quinazolines
4
2012
243
1.030
Why?
Camptothecin
4
2016
110
0.910
Why?
Receptor, Notch1
3
2015
62
0.870
Why?
Aldehyde Dehydrogenase
6
2017
101
0.870
Why?
Mice, Nude
16
2024
682
0.820
Why?
Haplotypes
4
2012
475
0.760
Why?
Phosphatidylinositol 3-Kinases
10
2018
361
0.720
Why?
Wnt Signaling Pathway
5
2024
170
0.650
Why?
Gene Dosage
3
2015
143
0.640
Why?
Neutrophils
13
2007
1210
0.630
Why?
Pancreatic Neoplasms
6
2024
880
0.620
Why?
src-Family Kinases
3
2017
95
0.600
Why?
Amyloid Precursor Protein Secretases
3
2014
79
0.600
Why?
Endotoxemia
9
2004
86
0.590
Why?
Anilides
2
2018
70
0.590
Why?
Enzyme Inhibitors
5
2016
827
0.590
Why?
Protein Kinase Inhibitors
9
2018
887
0.580
Why?
Biomarkers, Tumor
9
2018
1164
0.560
Why?
Mice
41
2024
16961
0.550
Why?
Acute Lung Injury
2
2011
280
0.530
Why?
Pyridines
4
2018
478
0.520
Why?
Cell Line, Tumor
21
2024
3186
0.510
Why?
Receptors, Notch
2
2015
84
0.510
Why?
Tankyrases
1
2016
14
0.510
Why?
Drug Discovery
1
2016
130
0.490
Why?
Polymorphism, Genetic
3
2007
637
0.470
Why?
NF-kappa B
13
2007
665
0.470
Why?
3' Untranslated Regions
2
2012
138
0.460
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2014
84
0.450
Why?
DNA Copy Number Variations
1
2015
168
0.450
Why?
Proto-Oncogene Proteins c-met
1
2014
74
0.440
Why?
Tetrahydronaphthalenes
1
2013
30
0.420
Why?
Valine
1
2013
81
0.410
Why?
Animals
44
2024
35391
0.410
Why?
Mitogen-Activated Protein Kinases
7
2014
312
0.390
Why?
Sepsis
3
2007
575
0.370
Why?
Lipopolysaccharides
9
2007
877
0.360
Why?
Signal Transduction
17
2018
4931
0.360
Why?
Proto-Oncogene Proteins
8
2018
636
0.340
Why?
Superoxide Dismutase
3
2008
342
0.340
Why?
Urokinase-Type Plasminogen Activator
2
2007
29
0.340
Why?
Cell Proliferation
13
2024
2373
0.330
Why?
Interleukins
1
2011
241
0.320
Why?
Hemorrhage
6
2004
680
0.320
Why?
Neoplasm Metastasis
4
2016
611
0.320
Why?
Class I Phosphatidylinositol 3-Kinases
3
2014
81
0.300
Why?
Heterografts
3
2018
133
0.290
Why?
HCT116 Cells
4
2018
78
0.280
Why?
Apoptosis
11
2018
2492
0.280
Why?
Carcinoma, Pancreatic Ductal
2
2024
269
0.280
Why?
SOXB1 Transcription Factors
2
2018
57
0.270
Why?
Azepines
2
2018
88
0.260
Why?
Promoter Regions, Genetic
1
2011
1207
0.260
Why?
Mutation
3
2012
3717
0.260
Why?
Benzimidazoles
3
2013
162
0.260
Why?
Immunoblotting
5
2015
305
0.250
Why?
beta Catenin
3
2016
225
0.240
Why?
Neutrophil Activation
5
2003
80
0.240
Why?
Receptors, Interleukin-1
1
2006
218
0.240
Why?
Humans
46
2024
129626
0.240
Why?
TOR Serine-Threonine Kinases
4
2018
398
0.230
Why?
Oligonucleotide Array Sequence Analysis
6
2015
756
0.230
Why?
Pyrimidines
2
2018
459
0.220
Why?
Intracellular Signaling Peptides and Proteins
2
2006
441
0.210
Why?
Adrenergic alpha-Antagonists
2
2002
33
0.210
Why?
Proto-Oncogene Proteins c-akt
8
2018
432
0.210
Why?
Mice, Inbred BALB C
10
2003
1250
0.210
Why?
Colonic Neoplasms
2
2016
242
0.210
Why?
Female
24
2018
68734
0.200
Why?
Aged
11
2016
22061
0.200
Why?
Adrenergic alpha-Agonists
1
2002
28
0.200
Why?
Proto-Oncogene Proteins c-raf
1
2002
45
0.200
Why?
Genetic Predisposition to Disease
1
2011
2274
0.200
Why?
Neuroimmunomodulation
1
2002
69
0.200
Why?
ras Proteins
3
2013
144
0.190
Why?
Middle Aged
12
2016
31136
0.190
Why?
Adrenergic beta-Agonists
1
2002
133
0.190
Why?
Adrenergic beta-Antagonists
2
2002
321
0.180
Why?
Hemoptysis
1
2000
35
0.170
Why?
Polymorphism, Single Nucleotide
4
2011
2060
0.170
Why?
In Situ Hybridization, Fluorescence
2
2012
313
0.170
Why?
Adult
11
2016
35599
0.170
Why?
Head and Neck Neoplasms
2
2016
544
0.160
Why?
Carcinoma, Squamous Cell
2
2016
627
0.160
Why?
Male
24
2016
63670
0.160
Why?
Cytokines
4
2005
2021
0.160
Why?
Cell Transformation, Neoplastic
2
2018
326
0.160
Why?
DNA Topoisomerases, Type II
2
2016
43
0.150
Why?
Transplantation, Heterologous
2
2016
192
0.150
Why?
CDC2 Protein Kinase
1
2018
31
0.150
Why?
MAP Kinase Kinase Kinases
2
2015
70
0.150
Why?
Oncogene Proteins v-abl
1
2017
5
0.140
Why?
Cyclic AMP Response Element-Binding Protein
4
2003
141
0.140
Why?
Mitogen-Activated Protein Kinase Kinases
3
2010
131
0.140
Why?
p38 Mitogen-Activated Protein Kinases
6
2007
276
0.140
Why?
Case-Control Studies
3
2011
3378
0.140
Why?
Gene Expression Profiling
4
2018
1687
0.140
Why?
Dasatinib
1
2017
54
0.140
Why?
Proto-Oncogene Proteins p21(ras)
5
2016
259
0.140
Why?
Immunohistochemistry
5
2017
1685
0.140
Why?
Angiogenesis Inhibitors
2
2018
219
0.130
Why?
Intercellular Signaling Peptides and Proteins
2
2015
374
0.130
Why?
Adenocarcinoma
2
2014
893
0.130
Why?
Neovascularization, Pathologic
2
2018
296
0.130
Why?
Receptors, Cell Surface
2
2012
381
0.130
Why?
Phosphatidylinositol 3-Kinase
1
2016
26
0.130
Why?
Axin Protein
1
2016
19
0.130
Why?
Aurora Kinase A
1
2016
54
0.130
Why?
Corynebacterium
1
2017
48
0.130
Why?
Antigens, Neoplasm
2
2016
308
0.130
Why?
Corynebacterium Infections
1
2017
40
0.130
Why?
Cell Cycle
5
2018
588
0.130
Why?
Transcription Factor 7-Like 2 Protein
1
2016
22
0.130
Why?
Neoplasms, Experimental
1
2017
170
0.130
Why?
Neoplasms
3
2016
2455
0.130
Why?
Neoplastic Stem Cells
2
2018
378
0.130
Why?
Aged, 80 and over
5
2014
7052
0.130
Why?
Autophagy
1
2018
266
0.120
Why?
RNA, Messenger
5
2016
2708
0.120
Why?
Serrate-Jagged Proteins
1
2015
27
0.120
Why?
Genotype
3
2012
1833
0.120
Why?
Jagged-1 Protein
1
2015
23
0.120
Why?
RNA, Small Interfering
2
2015
591
0.120
Why?
Drug Synergism
2
2014
370
0.120
Why?
Gene Duplication
1
2015
67
0.120
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2014
1560
0.120
Why?
Retinaldehyde
1
2015
5
0.120
Why?
Pyrazoles
1
2018
404
0.120
Why?
HMGB1 Protein
2
2007
49
0.120
Why?
Acetaldehyde
1
2015
17
0.120
Why?
Pyrimidinones
1
2015
102
0.120
Why?
Chemokines
5
2003
226
0.120
Why?
Acridines
1
2014
7
0.120
Why?
Neoplasm Transplantation
4
2016
256
0.110
Why?
Chemokine CXCL2
4
2001
43
0.110
Why?
Topoisomerase II Inhibitors
1
2014
24
0.110
Why?
Respiration, Artificial
2
2011
613
0.110
Why?
Pyridones
1
2015
158
0.110
Why?
Wnt Proteins
1
2015
127
0.110
Why?
Cell Cycle Proteins
1
2018
584
0.110
Why?
Benzazepines
1
2014
39
0.110
Why?
Calcium-Binding Proteins
1
2015
213
0.110
Why?
Gene Expression Regulation
2
2007
2542
0.110
Why?
Cell Growth Processes
1
2013
52
0.110
Why?
Cellular Senescence
1
2015
181
0.100
Why?
Disease Models, Animal
4
2018
4078
0.100
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2012
8
0.100
Why?
Tumor Suppressor Proteins
1
2015
314
0.100
Why?
DNA-Binding Proteins
3
2016
1445
0.100
Why?
Random Allocation
1
2013
347
0.100
Why?
Molecular Targeted Therapy
1
2015
391
0.100
Why?
Enzyme Activation
6
2003
813
0.100
Why?
Gene Knockdown Techniques
1
2013
317
0.100
Why?
Aldehyde Dehydrogenase, Mitochondrial
3
2017
23
0.100
Why?
Chemokine CXCL12
1
2012
79
0.100
Why?
Receptors, CXCR4
1
2012
83
0.100
Why?
Cyclosporine
1
2013
263
0.100
Why?
Linkage Disequilibrium
2
2012
257
0.100
Why?
Immunoprecipitation
1
2012
157
0.090
Why?
Lung
8
2004
3938
0.090
Why?
Lung Diseases
3
2004
741
0.090
Why?
Prognosis
3
2015
3774
0.090
Why?
Melanoma
1
2018
730
0.090
Why?
Hydroxamic Acids
1
2011
88
0.090
Why?
Drug Design
1
2012
158
0.090
Why?
Peroxidase
2
2002
175
0.090
Why?
Genetic Markers
1
2012
336
0.090
Why?
PTEN Phosphohydrolase
1
2012
161
0.090
Why?
Antibodies, Monoclonal, Humanized
2
2013
757
0.090
Why?
Sirolimus
1
2012
270
0.090
Why?
Genetic Association Studies
1
2012
362
0.080
Why?
Administration, Oral
1
2012
787
0.080
Why?
Histone Deacetylase Inhibitors
1
2011
209
0.080
Why?
Phosphorylation
3
2018
1713
0.080
Why?
Tumor Necrosis Factor-alpha
4
2004
1202
0.080
Why?
Cetuximab
3
2016
94
0.080
Why?
Cell Separation
1
2010
317
0.080
Why?
Membrane Proteins
1
2015
1125
0.080
Why?
Antibodies, Monoclonal
1
2015
1366
0.070
Why?
Gene Expression Regulation, Neoplastic
4
2016
1336
0.070
Why?
G2 Phase Cell Cycle Checkpoints
2
2018
45
0.070
Why?
Models, Statistical
1
2012
625
0.070
Why?
Genetic Variation
2
2012
939
0.070
Why?
Cells, Cultured
6
2007
4084
0.070
Why?
HT29 Cells
2
2018
36
0.070
Why?
Europe
1
2007
363
0.070
Why?
Gene Expression
2
2003
1465
0.070
Why?
Clinical Trials as Topic
2
2015
1005
0.070
Why?
ErbB Receptors
3
2016
607
0.070
Why?
Flow Cytometry
1
2010
1159
0.060
Why?
Genome, Human
1
2008
394
0.060
Why?
Thymine
1
2006
14
0.060
Why?
Cytosine
1
2006
48
0.060
Why?
Interleukin-1 Receptor-Associated Kinases
1
2006
27
0.060
Why?
Tumor Burden
2
2018
286
0.060
Why?
Phentolamine
2
2002
14
0.060
Why?
Translocation, Genetic
1
2006
96
0.060
Why?
Homozygote
1
2006
195
0.060
Why?
MAP Kinase Kinase 2
2
2002
28
0.060
Why?
Inflammation Mediators
2
2006
505
0.060
Why?
Adolescent
3
2011
20412
0.060
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2007
949
0.060
Why?
Propranolol
2
2002
50
0.060
Why?
MicroRNAs
1
2012
679
0.060
Why?
Survival Analysis
1
2008
1269
0.060
Why?
Cell Nucleus
2
2006
584
0.060
Why?
MAP Kinase Kinase 1
2
2002
75
0.060
Why?
Models, Biological
2
2018
1724
0.060
Why?
Spheroids, Cellular
2
2016
77
0.060
Why?
Introns
1
2006
251
0.060
Why?
Heat-Shock Proteins
1
2005
136
0.060
Why?
Mitogen-Activated Protein Kinase 3
2
2002
151
0.060
Why?
Exons
1
2006
342
0.060
Why?
Bone Marrow Cells
2
2003
302
0.060
Why?
Neoplasm Invasiveness
2
2016
481
0.060
Why?
Cause of Death
1
2006
395
0.050
Why?
Positron-Emission Tomography
2
2018
282
0.050
Why?
Shock, Septic
1
2006
209
0.050
Why?
Oxidants
1
2003
109
0.050
Why?
Organoids
1
2024
104
0.050
Why?
Deoxycytidine
1
2024
164
0.050
Why?
Paclitaxel
1
2024
217
0.050
Why?
Ribosomal Protein S6 Kinases
1
2002
21
0.050
Why?
Brimonidine Tartrate
1
2002
9
0.050
Why?
Models, Genetic
1
2005
593
0.050
Why?
Phenylephrine
1
2002
75
0.050
Why?
RNA Interference
2
2016
450
0.050
Why?
Hydrogen Peroxide
1
2003
317
0.050
Why?
Quinoxalines
1
2002
64
0.050
Why?
Lung Neoplasms
1
2015
2342
0.050
Why?
Isoenzymes
1
2003
301
0.050
Why?
Transcription, Genetic
2
2006
1418
0.050
Why?
Protein-Tyrosine Kinases
2
2002
431
0.050
Why?
Cyclic AMP-Dependent Protein Kinases
1
2002
133
0.050
Why?
Membrane Glycoproteins
1
2004
477
0.050
Why?
Free Radical Scavengers
1
2001
82
0.050
Why?
Neoplasm Proteins
3
2016
419
0.040
Why?
High Mobility Group Proteins
1
2000
42
0.040
Why?
Imidazoles
1
2001
234
0.040
Why?
MAP Kinase Signaling System
1
2002
313
0.040
Why?
Neutropenia
1
2000
137
0.040
Why?
Transcriptome
2
2016
876
0.040
Why?
Nuclear Proteins
2
2001
660
0.040
Why?
Interleukin-1
2
2000
961
0.040
Why?
Protein Processing, Post-Translational
1
2002
457
0.040
Why?
Adjuvants, Immunologic
1
2000
221
0.040
Why?
Trans-Activators
1
2001
393
0.040
Why?
M Phase Cell Cycle Checkpoints
1
2018
24
0.040
Why?
Colorado
1
2008
4404
0.040
Why?
4-Aminobenzoic Acid
1
2018
7
0.040
Why?
Up-Regulation
2
2016
840
0.040
Why?
Biomarkers
1
2008
3968
0.030
Why?
Pneumonia
1
2003
617
0.030
Why?
Protein Transport
1
2018
429
0.030
Why?
Retinal Dehydrogenase
1
2016
30
0.030
Why?
Inhibitory Concentration 50
1
2016
86
0.030
Why?
Hyaluronan Receptors
1
2016
97
0.030
Why?
Mice, Inbred C57BL
4
2015
5455
0.030
Why?
Blotting, Western
2
2013
1206
0.030
Why?
Protein Interaction Maps
1
2016
42
0.030
Why?
Tissue Array Analysis
1
2016
55
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
117
0.030
Why?
Papillomaviridae
1
2016
114
0.030
Why?
Drug Screening Assays, Antitumor
1
2016
191
0.030
Why?
Chromatin Immunoprecipitation
1
2016
132
0.030
Why?
Prospective Studies
1
2007
7135
0.030
Why?
S-Phase Kinase-Associated Proteins
1
2015
20
0.030
Why?
Diphenylamine
1
2014
9
0.030
Why?
Cadherins
1
2016
190
0.030
Why?
Iloprost
1
2015
45
0.030
Why?
Acid Phosphatase
1
2014
20
0.030
Why?
Young Adult
1
2011
12455
0.030
Why?
Rhodamines
1
2014
18
0.030
Why?
G2 Phase
1
2014
36
0.030
Why?
Cell Division
1
2016
796
0.030
Why?
Tumor Cells, Cultured
1
2016
943
0.030
Why?
Gene Expression Regulation, Enzymologic
1
2016
285
0.030
Why?
Inflammation
1
2005
2750
0.030
Why?
Sequence Analysis, RNA
1
2016
427
0.030
Why?
Epithelial-Mesenchymal Transition
1
2016
201
0.030
Why?
Tretinoin
1
2015
130
0.030
Why?
Benzamides
1
2014
203
0.030
Why?
Antigens, CD
1
2016
487
0.030
Why?
Retrospective Studies
1
2011
14522
0.030
Why?
Transfection
1
2016
915
0.030
Why?
Receptor, Notch2
1
2013
15
0.030
Why?
Gonanes
1
2013
27
0.030
Why?
Alphapapillomavirus
1
2013
39
0.030
Why?
Receptors, CXCR
1
2012
3
0.030
Why?
Erlotinib Hydrochloride
1
2012
70
0.020
Why?
Cyclin D1
1
2012
63
0.020
Why?
Disease-Free Survival
1
2014
646
0.020
Why?
Protein Binding
1
2018
2124
0.020
Why?
Tumor Suppressor Protein p53
1
2016
507
0.020
Why?
Myeloid Cell Leukemia Sequence 1 Protein
2
2003
40
0.020
Why?
Active Transport, Cell Nucleus
2
2003
113
0.020
Why?
Computers
1
2012
65
0.020
Why?
Mice, Inbred C3H
2
2004
272
0.020
Why?
Maximum Tolerated Dose
1
2012
193
0.020
Why?
Niacinamide
1
2012
75
0.020
Why?
Phenylurea Compounds
1
2012
88
0.020
Why?
Tissue Distribution
1
2012
315
0.020
Why?
Mice, Knockout
3
2003
2881
0.020
Why?
Injections, Intraperitoneal
2
2001
112
0.020
Why?
Proto-Oncogene Proteins c-myc
1
2012
131
0.020
Why?
Proto-Oncogene Proteins c-bcl-2
2
2003
234
0.020
Why?
Calcium Signaling
1
2013
250
0.020
Why?
Xanthine Oxidase
2
2001
78
0.020
Why?
Acute Disease
2
2004
979
0.020
Why?
United States
1
2007
13871
0.020
Why?
Cluster Analysis
1
2011
482
0.020
Why?
Nuclear Magnetic Resonance, Biomolecular
1
2011
260
0.020
Why?
Ligands
1
2011
621
0.020
Why?
Vascular Endothelial Growth Factor A
1
2012
530
0.020
Why?
Survival Rate
1
2014
1872
0.020
Why?
Models, Molecular
1
2014
1491
0.020
Why?
Computational Biology
1
2013
596
0.020
Why?
Tumor Microenvironment
1
2012
627
0.020
Why?
Dose-Response Relationship, Drug
1
2012
2011
0.020
Why?
Adiposity
1
2012
504
0.020
Why?
Cell Movement
1
2011
948
0.020
Why?
Mice, Transgenic
2
2003
2128
0.020
Why?
Calcium
1
2013
1212
0.020
Why?
Oxidative Stress
2
2003
1266
0.020
Why?
Magnetic Resonance Imaging
1
2018
3394
0.020
Why?
Neutrophil Infiltration
1
2004
105
0.010
Why?
Permeability
1
2004
157
0.010
Why?
Transcription Factor AP-1
1
2003
88
0.010
Why?
Phosphotransferases
1
2003
24
0.010
Why?
Class Ib Phosphatidylinositol 3-Kinase
1
2003
4
0.010
Why?
bcl-Associated Death Protein
1
2003
10
0.010
Why?
Toll-Like Receptors
1
2004
179
0.010
Why?
Aconitate Hydratase
1
2003
17
0.010
Why?
Algorithms
1
2010
1616
0.010
Why?
JNK Mitogen-Activated Protein Kinases
1
2003
161
0.010
Why?
Reproducibility of Results
1
2010
3080
0.010
Why?
Lipid Peroxidation
1
2003
151
0.010
Why?
Mice, Mutant Strains
1
2003
298
0.010
Why?
Extracellular Space
1
2003
120
0.010
Why?
Metalloporphyrins
1
2003
101
0.010
Why?
Replication Protein C
1
2001
4
0.010
Why?
Tumor Necrosis Factor alpha-Induced Protein 3
1
2001
11
0.010
Why?
Toll-Like Receptor 4
1
2004
264
0.010
Why?
bcl-X Protein
1
2001
42
0.010
Why?
Biological Transport
1
2003
404
0.010
Why?
Cysteine Endopeptidases
1
2001
68
0.010
Why?
CREB-Binding Protein
1
2001
27
0.010
Why?
Protein Kinases
1
2003
318
0.010
Why?
Transcription Factor RelA
1
2001
84
0.010
Why?
Tungsten
1
2001
30
0.010
Why?
Animal Feed
1
2001
50
0.010
Why?
Proto-Oncogene Proteins c-fos
1
2001
175
0.010
Why?
Immune Sera
1
2000
87
0.010
Why?
Mitogen-Activated Protein Kinase 1
1
2001
184
0.010
Why?
Organ Specificity
1
2000
296
0.010
Why?
Endotoxins
1
2000
220
0.010
Why?
Protein Biosynthesis
1
2001
410
0.010
Why?
Antioxidants
1
2003
558
0.010
Why?
Carrier Proteins
1
2003
745
0.010
Why?
Intubation, Intratracheal
1
2000
242
0.010
Why?
Peptides
1
2001
926
0.010
Why?
Treatment Outcome
1
2010
10219
0.010
Why?
Proteins
1
2001
944
0.010
Why?
Arcaroli's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)